The main aim was to establish suited analytical targets by analyzing human hepatocyte incubation samples with significant-resolution mass spectrometry (HRMS) and to substantiate the effects in authentic urine specimens and to determine AB-FUBINACA's metabolic security in human liver microsomes and as opposed hepatocyte and urine effects with in sil